ArticleJournal of thoracic disease2017

PD-1 targeted Immunotherapy as first-line therapy for advanced non-small-cell lung cancer patients.

Arik Bernard Schulze et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.